This educational activity is provided by Albert Einstein College of Medicine.
Supported by an educational grant from Boehringer Ingelheim.
Asthma is increasingly understood as a heterogeneous disease, with variants that respond differently to treatment. Optimal patient care depends on recognizing these differences and designing treatment plans accordingly. Inhaled treatment is the mainstay of asthma management, so in addition to considering such clinical aspects as symptoms, exacerbations, response to prior treatment, and rate of disease progression, clinicians must also consider the range of available inhalation devices available on the market. Because suboptimal inhalation technique by the patient can undermine asthma control, initial patient education on and ongoing monitoring of inhaler use are important factors in effective asthma management.
Pulmonologists, internists, hospitalists, family practice and general practice physicians, nurse practitioners, physician assistants, and other healthcare professionals who treat and manage asthma
At the conclusion of this activity, participants should be better able to:
Discuss the impact of asthma pathophysiology and phenotype on therapeutic choices and decisions for the management of asthma
Apply the National Asthma Education and Prevention Program (NAEPP) guidelines stepwise approach to care when individualizing treatment for asthmatic patients at different stages of disease severity, including uncontrolled asthma
Select an appropriate device based on patient needs and educate patients on the importance of adherence and proper inhaler technique to improve their overall outcomes
Conflict Of Interest Disclosure Policy
It is the policy of Albert Einstein College of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty participating in our programs are expected to disclose any relationships they may have with commercial companies whose products or services may be mentioned, so that participants may evaluate the objectivity of the presentations. In addition, any discussion of off-label, experimental, or investigational uses of drugs or devices will be disclosed by the faculty.
Nicola A. Hanania, MBBS, MD Associate Professor of Medicine Pulmonary and Critical Care Medicine Director, Asthma Clinical Research Center Baylor College of Medicine Houston, TX
Dr. Hanania receives grants/research support from Boehringer Ingelheim, Genentech, GlaxoSmithKline, Mylan Pharmaceuticals, and Sunovion Pharmaceuticals. He is a consultant for Genentech, Novartis, and Sunovion Pharmaceuticals. Dr. Hanania serves on the speakers' bureau for Genentech.
Course Director: David L. Rosenstreich, MD Professor, Departments of Medicine, Microbiology & Immunology, and Otorhinolaryngology Albert Einstein College of Medicine Chief, Division of Allergy & Immunology Department of Medicine Montefiore Medical Center Bronx, NY
Dr. Rosenstreich has received grant/research support from Genentech and Merck & Co. He is a consultant for GlaxoSmithKline.
Accredited Provider Disclosure
The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine has nothing to disclose with regard to commercial support.
Publishing Staff Disclosure
Jill Rovitzky Black, Eileen McCaffrey, and Rachel Moss of Haymarket Medical Education have nothing to disclose with regard to commercial support.
AMA PRA Category 1 Credit(s)TM
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Albert Einstein College of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Boehringer Ingelheim, Albert Einstein College of Medicine, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Boehringer Ingelheim, Albert Einstein College of Medicine, or Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
If you have any questions relating to the accreditation of this activity, please call Einstein CME at 718-920-6674.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.